BCSFX Financial Statements & Analysis
Complete financial statements for BCSFX including income statement, balance sheet, and cash flow statement. Analyze BCSFX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
189.2% ↑
Net Income
161.0% ↑
Gross Margin
-6.5% ↓
Operating Margin
-27.6% ↓
Balance Sheet
Current Ratio
42.2% ↑
Debt to Equity
2.8% ↓
Asset Turnover
180.3% ↑
Cash Flow
Operating Cash Flow
39.9% ↑
Net Cash Flow
146.1% ↑
Free Cash Flow
39.9% ↑
Cash Flow to Debt
21.4% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | -1.40B | 1.25B | 189.2% | |
| Gross Profit | -1.44B | 1.20B | 183.4% | |
| Operating Income | -1.59B | 1.03B | 164.6% | |
| Net Income | -1.64B | 1.00B | 161.0% | |
| EPS | -3.92 | 1.37 | 134.9% | |
| EBITDA | -154.60M | 2.08B | 1448.3% | |
| Gross Margin | 102.69% | 96.04% | 6.5% | |
| Operating Margin | 113.73% | 82.30% | 27.6% | |
| Net Income Margin | 117.47% | 80.29% | 31.6% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1.25B | -1.40B | 2.00B | — | — |
| Gross Profit | 1.20B | -1.44B | 1.97B | — | — |
| Operating Income | 1.03B | -1.59B | 1.82B | — | — |
| Net Income | 1.00B | -1.64B | 1.61B | — | — |
| EPS | 1.37 | -3.92 | 3.92 | — | — |
| EBITDA | 2.08B | -154.60M | 3.66B | — | — |
| Gross Margin | 96.04% | 102.69% | 98.74% | — | — |
| Operating Margin | 82.30% | 113.73% | 90.99% | — | — |
| Net Income Margin | 80.29% | 117.47% | 80.73% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into BCSFX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics